Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-viral T-cell Therapy by Gamma Capture for High-risk Patients With Acquired or Inherited Immune Defects

NCT06027879 is registered in ClinicalTrials.gov with Paul Szabolcs as lead sponsor.

NCT NCT06027879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06027879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-viral T-cell Therapy by Gamma Capture for High-risk Patients With Acquired or Inherited Immune Defects
Lead sponsor
Paul Szabolcs
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
January 8, 2024
Completion date
June 1, 2029
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenovirus, cytomegalovirus infections, epstein-barr virus infections